Rocket Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs f…
Biotechnology
US, Cranbury [HQ]

Cash Flow Statement

12 Sheets · From 2023 to 2012
Configuration
In Million USD. Margins, Growth Rates In %
Metric 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
-6.00 -6.00 -9.00 -17.00 -37.00 -26.00 -53.00 -64.00 -74.00 -121.00 -178.00 -194.00
Operating Cash (Net)
-6.00 -6.00 -9.00 -17.00 -37.00 -26.00 -53.00 -64.00 -74.00 -121.00 -178.00 -194.00
Accounts Receivable
- - - - - - - - - - - - - - - - - - - - - - - -
Accounts Payable
- - - - - - - - - - -1.00 5.00 -2.00 11.00 -4.00 9.00 10.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
- - - - - - -31.00 -66.00 75.00 -5.00 -39.00 -96.00 18.00 -69.00 -98.00
Capital Expenditure
- - - - - - - - - - - - -1.00 -23.00 -29.00 -7.00 -8.00 -16.00
Purchases of Investments
- - - - - - -33.00 -122.00 -27.00 -141.00 -184.00 -209.00 -245.00 -376.00 -390.00
Sale/Maturity of Investment
- - - - - - 2.00 56.00 102.00 61.00 168.00 141.00 272.00 272.00 309.00
Property, Plant, Equipment (P&PE)
- - - - - - - - - - - - -1.00 -23.00 -29.00 -7.00 -8.00 -16.00
Acquisitions (Net)
- - - - - - - - - - - - 76.00 - - 8.00 - - 42.00 - -
Other Investing Activities
- - - - - - - - - - - - - - - - -8.00 - - - - - -
Financing Activities
Used Cash (Net)
-2.00 -17.00 - - -125.00 - - - - -153.00 -177.00 -282.00 - - -155.00 -208.00
Debt Repayment
- - - - -1.00 -7.00 - - - - - - - - -5.00 - - - - - -
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - - - -
Common Stock
- - - - - - - - - - - - 154 177 281 - - 154 - -
Other Financing Activities
2.00 17.00 1.00 21.00 - - - - - - -1.00 12.00 - - - - - -
Cash Balances
Begin of Period
5.00 1.00 12.00 3.00 80.00 29.00 18.00 112.00 186.00 298.00 234.00 141.00
End of Period
1.00 12.00 3.00 80.00 29.00 78.00 112.00 186.00 298.00 234.00 141.00 57.00
Change
-4.00 11.00 -9.00 76.00 -50.00 48.00 94.00 74.00 111.00 -64.00 -92.00 -84.00
Non-Cash Balances
Depreciation and Amortization
- - - - - - - - - - - - - - - - 1.00 5.00 6.00 7.00
Stock Based Compensation
- - - - - - 2.00 2.00 4.00 - - 13.00 18.00 29.00 31.00 39.00
Other
- - - - 1.00 1.00 - - - - 2.00 3.00 29.00 13.00 - - - -
Highlighted metrics
Free Cash Flow (FCF)
-6.00 -6.00 -9.00 -17.00 -37.00 -26.00 -55.00 -87.00 -103.00 -128.00 -186.00 -211.00
Cash Conversion Cycle (CCC)
- - - - - - - - - - - - - - - - - - - - - - - -
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows